Cargando…
Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927996/ https://www.ncbi.nlm.nih.gov/pubmed/32499245 http://dx.doi.org/10.3324/haematol.2020.249094 |
_version_ | 1783659772588851200 |
---|---|
author | Zaliova, Marketa Potuckova, Eliska Lukes, Julius Winkowska, Lucie Starkova, Julia Janotova, Iveta Sramkova, Lucie Stary, Jan Zuna, Jan Stanulla, Martin Zimmermann, Martin Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Cario, Gunnar Trka, Jan |
author_facet | Zaliova, Marketa Potuckova, Eliska Lukes, Julius Winkowska, Lucie Starkova, Julia Janotova, Iveta Sramkova, Lucie Stary, Jan Zuna, Jan Stanulla, Martin Zimmermann, Martin Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Cario, Gunnar Trka, Jan |
author_sort | Zaliova, Marketa |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7927996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-79279962021-03-05 Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia Zaliova, Marketa Potuckova, Eliska Lukes, Julius Winkowska, Lucie Starkova, Julia Janotova, Iveta Sramkova, Lucie Stary, Jan Zuna, Jan Stanulla, Martin Zimmermann, Martin Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Cario, Gunnar Trka, Jan Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-06-04 /pmc/articles/PMC7927996/ /pubmed/32499245 http://dx.doi.org/10.3324/haematol.2020.249094 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letters to the Editor Zaliova, Marketa Potuckova, Eliska Lukes, Julius Winkowska, Lucie Starkova, Julia Janotova, Iveta Sramkova, Lucie Stary, Jan Zuna, Jan Stanulla, Martin Zimmermann, Martin Bornhauser, Beat Bourquin, Jean-Pierre Eckert, Cornelia Cario, Gunnar Trka, Jan Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title | Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title_full | Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title_fullStr | Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title_full_unstemmed | Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title_short | Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia |
title_sort | frequency and prognostic impact of zeb2 h1038 and q1072 mutations in childhood b-other acute lymphoblastic leukemia |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927996/ https://www.ncbi.nlm.nih.gov/pubmed/32499245 http://dx.doi.org/10.3324/haematol.2020.249094 |
work_keys_str_mv | AT zaliovamarketa frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT potuckovaeliska frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT lukesjulius frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT winkowskalucie frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT starkovajulia frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT janotovaiveta frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT sramkovalucie frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT staryjan frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT zunajan frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT stanullamartin frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT zimmermannmartin frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT bornhauserbeat frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT bourquinjeanpierre frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT eckertcornelia frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT cariogunnar frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia AT trkajan frequencyandprognosticimpactofzeb2h1038andq1072mutationsinchildhoodbotheracutelymphoblasticleukemia |